These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24500836)

  • 1. Long-term, high-dose intravenous immunoglobulin therapy in a patient with banker-type juvenile dermatomyositis.
    Imataka G; Arisaka O
    Cell Biochem Biophys; 2014 Jul; 69(3):747-8. PubMed ID: 24500836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety.
    Al-Mayouf SM; Laxer RM; Schneider R; Silverman ED; Feldman BM
    J Rheumatol; 2000 Oct; 27(10):2498-503. PubMed ID: 11036850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with high-dose recombinant human hyaluronidase-facilitated subcutaneous immune globulins in patients with juvenile dermatomyositis who are intolerant to intravenous immune globulins: a report of 5 cases.
    Speth F; Haas JP; Hinze CH
    Pediatr Rheumatol Online J; 2016 Sep; 14(1):52. PubMed ID: 27623619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous Immunoglobulin in Refractory Juvenile Dermatomyositis.
    de Inocencio J; Enríquez-Merayo E; Casado R; González-Granado LI
    Pediatrics; 2016 Apr; 137(4):. PubMed ID: 26966131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of intravenous Ig therapy in juvenile dermatomyositis.
    Lam CG; Manlhiot C; Pullenayegum EM; Feldman BM
    Ann Rheum Dis; 2011 Dec; 70(12):2089-94. PubMed ID: 21978999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose intravenous immunoglobulin therapy for intractable dermatomyositis skin lesions.
    Sadayama T; Miyagawa S; Shirai T
    J Dermatol; 1999 Jul; 26(7):457-9. PubMed ID: 10458087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid and sustained response to JAK inhibition in a child with severe MDA5 + juvenile dermatomyositis.
    Strauss T; Günther C; Schnabel A; Wolf C; Hahn G; Lee-Kirsch MA; Brück N
    Pediatr Rheumatol Online J; 2023 Sep; 21(1):104. PubMed ID: 37726751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis ("ProDERM Study").
    Aggarwal R; Charles-Schoeman C; Schessl J; Dimachkie MM; Beckmann I; Levine T
    Medicine (Baltimore); 2021 Jan; 100(1):e23677. PubMed ID: 33429735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin therapy in juvenile dermatomyositis.
    Tsai MJ; Lai CC; Lin SC; Chiang BL; Chou CC; Hsieh KH
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(2):111-5. PubMed ID: 9151463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
    Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile dermatomyositis: recognition and treatment.
    Reed AM; Lopez M
    Paediatr Drugs; 2002; 4(5):315-21. PubMed ID: 11994036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis.
    Saito E; Koike T; Hashimoto H; Miyasaka N; Ikeda Y; Hara M; Yamada H; Yoshida T; Harigai M; Ichikawa Y
    Mod Rheumatol; 2008; 18(1):34-44. PubMed ID: 18217197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of childhood dermatomyositis with high dose intravenous immunoglobulin.
    Vedanarayanan V; Subramony SH; Ray LI; Evans OB
    Pediatr Neurol; 1995 Nov; 13(4):336-9. PubMed ID: 8771171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravenously-administered immunoglobulins as first-choice agent in juvenile dermatomyositis].
    Breems DA; de Haas PW; Visscher F; Sabbe LJ; Busch HF; van Doorn PA
    Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1979-82. PubMed ID: 8413708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: adverse reactions are associated with immunoglobulin A content.
    Manlhiot C; Tyrrell PN; Liang L; Atkinson AR; Lau W; Feldman BM
    Pediatrics; 2008 Mar; 121(3):e626-30. PubMed ID: 18299304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable outcome of juvenile dermatomyositis treated without systemic corticosteroids.
    Levy DM; Bingham CA; Kahn PJ; Eichenfield AH; Imundo LF
    J Pediatr; 2010 Feb; 156(2):302-7. PubMed ID: 19846111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin is an effective treatment for refractory cutaneous dermatomyositis.
    Galimberti F; Kooistra L; Li Y; Chatterjee S; Fernandez AP
    Clin Exp Dermatol; 2018 Dec; 43(8):906-912. PubMed ID: 29856076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.
    Quintana-Ortega C; Remesal A; Ruiz de Valbuena M; de la Serna O; Laplaza-González M; Álvarez-Rojas E; Udaondo C; Alcobendas R; Murias S
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):101-107. PubMed ID: 33019894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood Arthritis and Rheumatology Research Alliance Consensus Clinical Treatment Plans for Juvenile Dermatomyositis with Persistent Skin Rash.
    Huber AM; Kim S; Reed AM; Carrasco R; Feldman BM; Hong SD; Kahn P; Rahimi H; Robinson AB; Vehe RK; Weiss JE; Spencer C;
    J Rheumatol; 2017 Jan; 44(1):110-116. PubMed ID: 27803135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin in juvenile dermatomyositis--four year review of nine cases.
    Sansome A; Dubowitz V
    Arch Dis Child; 1995 Jan; 72(1):25-8. PubMed ID: 7717731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.